Company Earnings UpdateLoblaw (TSX: L) 2Q19 Results: Food Growth Softens Coresight Research July 25, 2019 Executive Summary In 2Q19, ended June 15, Loblaw reported a meaningful weakening of comparable sales growth in its food segment. Food retail comp growth of 0.6% compared to 2.0% in the prior quarter and was well below company-measured food-price inflation of 3.6%. Drug retail comp growth strengthened to 4.0% in 2Q19, from 2.2% in the prior quarter. Management maintained FY19 guidance for positive same-store sales and a stable gross margin in the retail segment. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: JCPenney Merges with SPARC Group to Form Catalyst Brands—What It Means for US RetailInsights from China’s National Day Golden Week 2025: Resilience and Evolution in Consumer DemandThe New Coresight 100: Leading the Retail Charge in 2025Innovator Profile: Wayvee Analytics—Analyzing Customer Emotions to Boost Store and Shelf Performance
